Takeshi Kamomae

Papers

Total Citations

H-Index

About

Takeshi Kamomae is a leading figure in the advancement of stereotactic body radiation therapy (SBRT), with a primary focus on enhancing precision in prostate cancer treatment. His key research centers on the clinical application of multileaf collimators (MLCs) in robotic radiosurgery systems, a technology that has revolutionized the field by offering superior conformity and dose distribution compared to traditional circular collimators. Kamomae’s most-cited work, a 2017 study on the clinical usefulness of MLCs for prostate SBRT, has garnered 12 citations and serves as a foundational reference for clinicians adopting this technique. By systematically evaluating the benefits of MLCs—including improved target coverage and reduced toxicity to surrounding healthy tissue—he has provided critical evidence supporting their integration into routine practice. His contributions have directly influenced treatment planning protocols, helping to make SBRT a more effective and safer option for localized prostate cancer. Kamomae’s research continues to shape the evolution of precision radiotherapy, bridging the gap between technological innovation and tangible clinical outcomes.